Peer-reviewedCC BYTouchREVIEWS in endocrinology1 Oct 2026

Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is

Sanja Borozan¹
Cornelius J Fernandez²
ABM Kamrul-Hasan³
Sunil Nair⁴
Joseph M Pappachan⁴

4 affiliations

¹Department of Endocrinology, Clinical Centre of Montenegro, & Faculty of Medicine, Podgorica, Montenegro
²Department of Endocrinology & Metabolism, Pilgrim Hospital, United Lincolnshire Hospitals NHS Trust, Boston, UK
³Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh
⁴Department of Endocrinology, Countess of Chester Hospital NHS Trust, Chester, UK

Read full text PDF Cite

Depression, functional disability, and cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationally representative cohort study
Jianxing Chen, Yujia Zhou, Cankun Yu +3
Scientific Reports16 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
Machine learning based predictive model for cardiovascular disease mortality risk in patients with stage 4 cardiovascular–kidney–metabolic syndrome
Pengyu Zhang, Sining Wang, He Yang +6
Medicine23 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
The role of sitagliptin in modifying metabolic, hormonal and clinical parameters in polycystic ovarian syndrome patients: a randomized controlled trial
Ahmed E. Altyar, Dina Y. Dessouky, Sara Abdallah Mohamed Salem +2
Frontiers in pharmacology16 Oct 2026Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
The path to treating multiple-etiology dementia: Combining vascular risk control and disease-modifying neurodegenerative therapies
Adam de Havenon, Kevin N. Sheth, Carolyn A. Fredericks +1
Neurotherapeutics24 Oct 2026Peer-reviewedCC BYFull textPsychiatry & mental healthDOAJ
Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive Control of Atherosclerotic Cardiovascular Disease Risk in Patients with Homozygous Familial Hypercholesterolemia
Hiroshi Yoshida
Journal of Atherosclerosis and Thrombosis11 Sep 2026Peer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaJ-STAGE

Cite

BibTeX RIS

BibTeX

@article{borozan2026diseasemodifying,
  title = {{Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is}},
  author = {Sanja Borozan and Cornelius J Fernandez and ABM Kamrul-Hasan and Sunil Nair and Joseph M Pappachan},
  journal = {TouchREVIEWS in endocrinology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13730172},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is
AU  - Sanja Borozan
AU  - Cornelius J Fernandez
AU  - ABM Kamrul-Hasan
AU  - Sunil Nair
AU  - Joseph M Pappachan
PY  - 2026
DA  - 2026/10/01
JO  - TouchREVIEWS in endocrinology
UR  - https://europepmc.org/article/PMC/PMC13730172
SN  - 2752-5457
ER  -

Related

Cite